Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Body fat, metabolic changes before pancreatic cancer diagnosis may aid in early detection
In the 36 months prior to diagnosis of pancreatic ductal adenocarcinoma, researchers observed “predominant changes” in patients’ body composition and biochemical markers, which may serve as potential biomarkers for early cancer detection.
Timing of adjuvant chemotherapy affects outcomes after colorectal cancer surgery
Timing of adjuvant chemotherapy initiation may affect outcomes among patients who undergo surgery for colorectal cancer, according to data published in JAMA Surgery.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: AI chatbot helps make colonoscopy prep ‘a little less painful’ for patients
AI has already made its mark in gastroenterology as a tool for detecting gastrointestinal lesions, adenomas and inflammatory bowel disease. However, its next phase of evolution might seem the most unlikely: Aiding colonoscopy preparation.
Nearly half of cancer deaths among U.S. adults attributable to modifiable risk factors
About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.
CRC screening trials exhibit ‘good adherence’ to guidelines, but improvements needed
Although adherence to standardized reporting guidelines ranged from 82.4% to 92.2% in published trials of colorectal cancer screening, researchers found that reporting of trial registration and informed consent materials could be improved.
Risk score has ‘superior ability’ to predict LT waitlist dropout among patients with HCC
A continuous risk score accurately predicted waitlist dropout and post-liver transplantation outcomes in patients with hepatocellular carcinoma, even over the course of several UNOS policy changes, researchers reported.
CRC screening based on fecal hemoglobin levels could reduce other testing by up to 49%
Using fecal hemoglobin concentrations to guide colorectal cancer screening intervals reduced the number of fecal immunochemical tests and colonoscopies by 49% and 28%, respectively, compared with biennial screening, data showed.
Individuals with high genetic risk for gastric cancer may benefit from H. pylori treatment
Treatment for Helicobacter pylori infection was associated with reduced risk for gastric cancer among patients with a high genetic risk, suggesting that chemoprevention should be personalized to genetic risk, according to data.
Adagrasib plus cetuximab receives accelerated approval to treat advanced colorectal cancer
The FDA granted accelerated approval adagrasib with cetuximab for the treatment of KRASG12C -mutated locally advanced or metastatic colorectal cancer, according to a press release from the agency.
National accreditation program linked to better outcomes after major rectal cancer surgery
National Accreditation Program for Rectal Cancer accreditation appeared associated with better outcomes for older adults who underwent major rectal cancer surgery, according to findings in Journal of the American College of Surgeons.
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read